Clinical Infectious Diseases

Hedberg C W, MacDonald K L and Osterholm M T (1994), Changing epidemiology of food-borne disease a Minnesota perspective , Clinical Infectious Diseases, 18, 671-682. 

De Vriese, A.S. et al. (2006) Linezolid-induced inhibition of mitochondrial protein synthesis. Clinical Infectious Diseases, 42 (8), 1111-1117. 

Kaplan, J.E., Hanson, D., Dworkin, M.S., Frederick, T., Bertolli, J., Lindegren, M.L., Holmberg, S. and Jones, J.L. (2000) Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clinical Infectious Diseases, 30, S5—S14. 

Tan, Litjen, and the American Medical Association. 2006. Strengthening the Supply of Routinely Recommended Vaccines in the United States A Perspective from the American Medical Association. Clinical Infectious Diseases 42(Suppl. 3) S121-S124. 

Fridkin S.K., J. Hageman, L.K. McDougal, et al. (2003). Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin. United States, 1997-2001. Clinical Infectious Diseases 36 429 39. 

S. A. Roberts, J. Robson, K. Read, N. Bak, J. Hurley, P.D.R. Johnson, A.J. Morris, B.C. Mayall, and M.L. Grayson (2004). Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clinical Infectious Diseases 38 521-528. 

Levine D.P. (2006). Vancomycin A history. Clinical Infectious Diseases 42 S5-S12. 

Whitener C.J., S.Y. Park, F.A. Browne, L.J. Parent, K. Julian, B. Bozdogan, P.C. Appelbautn, J. Chaitram, L.M. Weigel, J. Jemigan, L.K. McDougal, F.C. Tenover, and S.K. Fridkin (2004). Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clinical Infectious Diseases 38 1049-1055. 

Lipsky BA, Berendt AR, Deery HG et al. (2004) Diagnosis and treatment of diabetic foot infections. Clinical Infectious Diseases 39 885-910. 

Stevens DL, Bisno AL, Chambers HF et al. (2005) Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clinical Infectious Diseases 41 1373-1406. 

O Tool, T, Mair, M., lnglesby, T. (2002). Shining light on Dark Winter. Clinical Infectious Diseases, 34, 972-983. 

Ingelsby, T., Grossman, R., O Toole (2001). A plague on your city Observations from TOPOFF. Clinical Infectious Diseases, 32, 436-445. 

Fine, A., Layton, M. (2001). Lessons from the West Nile viral encephalitis outbreak in New York City, 1999 Implications for bioterrorism preparedness. Clinical Infectious Diseases, 32, 277-282. 

Asnis, D. S., Conetta, R., Teixeira, A. A., Waldman, G., Sampson, B. A. (2000). The West Nile virus outbreak of 1999 in New York The Flushing Hospital experience. Clinical Infectious Diseases, 30, 413-418. 

Fauci, A. S. (2001). Infectious diseases Considerations for the 21st century. Clinical Infectious Diseases, 32(5), 67-85. 

Jeffrey S. Sartin, Infectious Diseases During the Civil War The Triumph of the Third Army, Clinical Infectious Diseases 16 (1993) 582 and Paul E. Steiner, Diseases in the Civil Whr (Springfield, IE Charles C Thomas, 1968), p. 17. 

Quinupristin/dalfopristin, a new addition to the antimicrobial arsenal. Lancet 354 2012-2013 Kelkar P S, Li J T-C 2001 Cephalosporin allergy. New England Journal of Medicine 345 804—809 Moellering R C 1998 Vancomycin-resistant enterococci. Clinical Infectious Diseases 26 1196-1199... 

Mardani, M, Jahromi, MK, Naieni, KH, Zeinali, M. The Efficacy of Oral Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Eever in Iran. Clinical Infectious Diseases, 36(12) 1613-1618, 2003... 

Hughes, WT, Armstrong, DN, Bodey, GP, et al. Guidelines for the use of Antimicrobial Agents in Neutropenic patients with Cancer. Clinical Infectious Diseases, 34 730-751, 2002. 

As mentioned previously, some infectious diseases pharmacists have established effective clinical practices in the outpatient setting. The most common example of this is the presence of a pharmacist in an HIV clinic. The myriad of antimicrobial drug interactions and adverse effects associated with antiretroviral therapy, the need to periodically assess antiretroviral efficacy, and the considerable potential for noncompliance literally necessitate the need for a pharmacist in any established HIV clinic. Infectious diseases pharmacists work with infectious diseases and/or immunology physicians. Pharmacists conduct medication histories and answer drug information questions. In some settings, they may act under protocol to assess patient response to antiretroviral therapy based on virologic and immunologic measures, and to make appropriate modifications in therapy. 

Clinical Infectious Diseases—This journal, formerly named Reviews of Infectious Diseases, is an official publication of the IDSA. Articles are primarily directed at the diagnosis and treatment of infectious diseases, including clinical trials. Frequently, State of the Art articles are published that summarize current therapy of a particular infection. In addition, IDSA guidelines for the treatment of infectious diseases are published in this journal. 

The Journal of Infectious Diseases—This journal is also published by IDSA. The contents of this journal are generally directed at the cellular mechanisms of pathogenesis and immunity of infection. From a pharmacist practitioner standpoint, it is of less usefulness than Clinical Infectious Diseases. 

Talbot, G.H., Bradley, J., Edwards, f.E., fr., Gilbert, D., Scheld, M., and Bartlett, f.G. (2006) Bad bugs need drugs an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clinical Infectious Diseases,... 

Hooper, D.C. (2001) Mechanisms of action of antimicrobials focus on fluoroquinolones. Clinical Infectious Diseases, 32 (Suppl 1), S9-S15. 

Anaissie, E. (1992) Opportunistic mycoses in the immunocompromised host experience at a cancer center and review. Clinical Infectious Diseases, 14 (Suppl 1), S43-S53. 

Sinave, C., Le Templier, G., Blouin, D., Leveille, F. and Deland, E. (2002) Toxic shock syndrome due to Clostridium sordellii a dramatic postpartum and postabortion disease. Clinical Infectious Diseases, 35, 1441-1443. 

Hulse M, Johnson S, and Ferrieri P. (1993) Agrobacterium infections in humans experience at one hospital and review. Clinical Infectious Diseases 16 112-117. 

Source Clinical Infectious Diseases an Official Pubhcation of the Infectious Diseases Society of America. 

Sanders, M. E., Probiotics Definition, sources, selection, and uses. Clinical Infectious Diseases flOOS)-. 46, S58-S61. 

Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N, Mahajan R et al. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients 2-year treatment outcomes in Bihar, India. Clinical Infectious Diseases. 2011 53(7) e91-e98. 

Rauch A, Nolan D, Martin A, McKinnon E, Almeida C, MaUal S. Prosp>ective genetic screening decreases the incidence of abacavir h5 ersensitivity reactions in the western Australian HIV cohort study. Clinical Infectious Diseases, 43 99-102,2006. 

Lipsky BA, Baker GA. 1999. Fluoroquinolone toxicity profiles A review focusing on newer agents. Clinical Infectious Diseases 28(2) 352-364. 

J.W. Hiemenz and TJ. Walsh, Clinical Infectious Diseases, 1996,22, Supplement 2, SI33. 

---